Department of Surgery, Copenhagen University Hospital, North Zealand, Hillerød, Denmark.
Department of Clinical Medicine, Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Colorectal Dis. 2023 Mar;25(3):413-419. doi: 10.1111/codi.16383. Epub 2022 Nov 13.
Previous studies have shown favourable short-term results after Bascom's pit-pick procedure for simple pilonidal sinus disease. A minimum 5-year follow-up is considered the gold standard but only a few long-term studies have previously been reported. Here, we aimed to estimate the long-term risk of treatment failure, incomplete wound healing or recurrence, postoperative complications and patient reported outcome measures such as chronic pain and satisfaction with cosmetic appearance.
Medical records of patients registered in a local database after undergoing Bascom's pit-pick procedure were reviewed and follow-up data updated. The patients received an online survey including questions about demographics, lifestyle, complications, reintervention, pain, satisfaction with cosmetic appearance and supplemented with telephone interviews if no response was received.
A total of 158 patients underwent Bascom's pit-pick procedure during the period August 2007 to March 2014. Median follow-up was 7.98 (0.66, 10.96) years. Twelve patients (8%) had reintervention due to incomplete wound healing. A total of 32 patients experienced a recurrence. In competing risk analyses, the 10-year cumulative recurrence rate was 27% (95% CI: 19%-35%) of patients with complete wound healing. Treatment success was 68%. Recurrence was associated with active smoking, HR of 5.30 (95% CI: 1.42-19.86; p = 0.01), and number of primary pits ≥3, HR of 5.11 (95% CI: 1.49-17.47; p = 0.01). More than 90% had no postoperative complications or chronic pain, and more than 70% reported a high satisfaction with the cosmetic appearance.
Bascom's pit-pick seems to be adequate treatment for most patients with a simple pilonidal sinus.
既往研究显示,Bascom 的切刮术治疗单纯性藏毛窦疾病可获得良好的短期效果。目前认为 5 年以上随访是金标准,但既往仅有少数长期研究。本研究旨在评估治疗失败、伤口愈合不全或复发、术后并发症以及患者报告的结局测量(如慢性疼痛和对美容外观的满意度)的长期风险。
回顾性分析了 2007 年 8 月至 2014 年 3 月期间在当地数据库中登记并接受 Bascom 的切刮术的患者的病历,并更新了随访数据。患者收到了一份在线调查问卷,内容包括人口统计学、生活方式、并发症、再次干预、疼痛、对美容外观的满意度等问题,如果未收到回复,则进行电话访谈。
共 158 例患者接受了 Bascom 的切刮术治疗。中位随访时间为 7.98(0.66,10.96)年。12 例(8%)患者因伤口愈合不全而再次干预。共有 32 例患者复发。在竞争风险分析中,完全愈合的患者 10 年累积复发率为 27%(95%CI:19%-35%)。治疗成功率为 68%。复发与吸烟有关,HR 为 5.30(95%CI:1.42-19.86;p=0.01),原发性窦道≥3 个,HR 为 5.11(95%CI:1.49-17.47;p=0.01)。超过 90%的患者无术后并发症或慢性疼痛,超过 70%的患者对美容外观高度满意。
Bascom 的切刮术似乎是治疗单纯性藏毛窦疾病的有效方法。